Xiangyu MedicalLtd Future Growth
Future criteria checks 3/6
Xiangyu MedicalLtd is forecast to grow earnings and revenue by 21.1% and 19.9% per annum respectively. EPS is expected to grow by 20.6% per annum. Return on equity is forecast to be 13.6% in 3 years.
Key information
21.1%
Earnings growth rate
20.6%
EPS growth rate
Medical Equipment earnings growth | 22.8% |
Revenue growth rate | 19.9% |
Future return on equity | 13.6% |
Analyst coverage | Low |
Last updated | 20 May 2024 |
Recent future growth updates
Recent updates
Xiangyu MedicalLtd (SHSE:688626) Seems To Use Debt Quite Sensibly
Jul 04Xiangyu MedicalLtd's (SHSE:688626) Performance Raises Some Questions
Apr 24CN¥50.78: That's What Analysts Think Xiangyu Medical Co.,Ltd (SHSE:688626) Is Worth After Its Latest Results
Apr 21Capital Allocation Trends At Xiangyu MedicalLtd (SHSE:688626) Aren't Ideal
Apr 18Pinning Down Xiangyu Medical Co.,Ltd's (SHSE:688626) P/E Is Difficult Right Now
Mar 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,333 | 412 | 307 | 464 | 3 |
12/31/2025 | 1,106 | 339 | -84 | 408 | 3 |
12/31/2024 | 903 | 277 | -193 | 313 | 3 |
3/31/2024 | 771 | 228 | -302 | 209 | N/A |
12/31/2023 | 745 | 227 | -251 | 228 | N/A |
9/30/2023 | 674 | 212 | -201 | 267 | N/A |
6/30/2023 | 602 | 193 | -89 | 269 | N/A |
3/31/2023 | 547 | 154 | -19 | 247 | N/A |
12/31/2022 | 489 | 125 | -16 | 187 | N/A |
9/30/2022 | 529 | 163 | -23 | 184 | N/A |
6/30/2022 | 528 | 156 | -42 | 148 | N/A |
3/31/2022 | 508 | 177 | -21 | 137 | N/A |
12/31/2021 | 523 | 202 | 32 | 166 | N/A |
9/30/2021 | 533 | 212 | 34 | 199 | N/A |
6/30/2021 | 526 | 205 | 46 | 189 | N/A |
3/31/2021 | 531 | 210 | 107 | 246 | N/A |
12/31/2020 | 496 | 196 | 77 | 216 | N/A |
12/31/2019 | 427 | 129 | 135 | 156 | N/A |
12/31/2018 | 359 | 80 | 67 | 74 | N/A |
12/31/2017 | 289 | 64 | N/A | 59 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688626's forecast earnings growth (21.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 688626's earnings (21.1% per year) are forecast to grow slower than the CN market (21.8% per year).
High Growth Earnings: 688626's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688626's revenue (19.9% per year) is forecast to grow faster than the CN market (13.4% per year).
High Growth Revenue: 688626's revenue (19.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688626's Return on Equity is forecast to be low in 3 years time (13.6%).